发明名称
摘要 Fimbriae adhesins have a molecular weight of 2x10<5> and 2x10<7> Da, and comprise 90-95% protein and 1-3% sugar. Type 1 fimbriae show 5 different protein fractions of 14-20 kDa, most of which are associated to carbohydates. Type P fimbriae also include 5 different protein fractions of 14-20 kDa, one of the majority ones being associated to carbohydrates. The process comprises: culturing E. coli strains CECT 4484 and CECT 4485; collecting the sediment by centrifugation, resuspending it in physiological saline and homogenizing it; centrifuging the homogenate collecting the supernatant, which is subjected to saline precipitation, reconstituting the precipitate and dialyzing the solution; treating the dialyzate with sodium deoxcholate and, subjecting the product to two successive chromatographies with Sephacryl S-200 and Sepharose 4B. Use in treating and preventing infections of the urinary tract produced by fimbriated E. coli.
申请公布号 JP2851556(B2) 申请公布日期 1999.01.27
申请号 JP19950016819 申请日期 1995.02.03
申请人 INDOSUTORIARU PHARM I DE ESUPESHIARIDADESU SA 发明人 RIKARUDO PARASHIOSU PERAESU;ARUBERUTO MARUTEINESU GARATE;HORUHE MARUTEINESU KESAADA
分类号 G01N33/53;A61K38/00;A61K39/00;A61P13/02;C07K14/195;C07K14/245;C07K14/41;C12P21/00;C12R1/19;G01N33/569;(IPC1-7):C07K14/245 主分类号 G01N33/53
代理机构 代理人
主权项
地址